We're attending BIO China 2026 in Guangzhou, China, on 12–14 March 2026.

Bringing together global leaders in biotechnology, life sciences, and biopharmaceutical innovation, BIO China serves as a major platform for scientific exchange, strategic partnerships, and the advancement of cutting‑edge technologies shaping the future of healthcare.

Representing Richmond Pharmacology:

  • Stephen Wilkinson, Business Development Manager

Our Focus at the Exhibition

  • Emerging biotechnology platforms and therapeutic innovations
  • Global clinical development strategies and regulatory pathways
  • Strengthening cross‑border collaboration and partnering opportunities
  • Advances in early‑phase clinical trial design
  • Building sustainable scientific and commercial relationships in the Asia‑Pacific region

Connect With Us

If you are attending BIO China 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: BIOCHINA

Latest news

Richmond Pharmacology Appoints Adam Hurd as Operations Director

August 17, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Adam Hurd as Operations Director
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event